USC joins LA-area stem cell institutes in forming a regenerative medicine consortium
USC is partnering with seven of Los Angeles’ leading regenerative medicine institutes to form the Los Angeles and surrounding area regenerative medicine consortium (LA-RMC), with the goal of fulfilling the promise of the California Institute for Regenerative Medicine (CIRM): to develop laboratory discoveries into treatments for patients with unmet medical needs.
CIRM, the voter-created agency that provides public funding for stem cell research in California, is dedicated to advancing regenerative medicine, which uses stem cells and related approaches to treat disease and disorders. Regenerative approaches may apply cell-based treatments directly in a patient or use gene therapies to correct genetic disorders affecting normal tissue functions. In addition, stem cell-directed disease modeling provides new insights for therapy development and a platform to screen for disease-fighting drugs.
CIRM has provided a transformative source of research funding for the regenerative medicine consortium partners in the Los Angeles area:
Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC
Cedars-Sinai Board of Governors Regenerative Medicine Institute
City of Hope
California Institute of Technology
University of California, Irvine, Sue and Bill Gross Stem Cell Research Center
UCLA Broad Stem Cell Research Center
University of California, Riverside, Stem Cell Center
University of California, Santa Barbara, Center for Stem Cell Biology and Engineering
The consortium partners will meet annually to discuss opportunities for collaboration and for maximizing CIRM’s investment in accelerating the future of regenerative medicine.
At the first of these meetings, a recent three-day summit organized by Cedars-Sinai and held at Lake Arrowhead, more than 100 participants discussed working together on educational courses, cell and gene therapy manufacturing, shared research facilities providing core services such as microscopy, scientific innovations, and clinical trials.
“LA has tremendous strength with a depth of world-class institutions. As the field of regenerative medicine matures, it becomes increasingly important for us to collaborate across institutes,” said Andy McMahon, director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC. “This is the ideal moment for us to formalize our ongoing commitment to working together, maximizing the potential of CIRM support towards our shared goal of bringing stem cell therapies to patients.”
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Australian researchers at WEHI have found that a genetic change that increases the risk of inflammation, through a process described as ‘explosive’ cell death, is carried by up to 3% of the global population.
The study may explain why some people have an increased chance of developing conditions like inflammatory bowel disease or suffer more severe reactions to infections with bacteria like Salmonella.
At a glance
MLKL is a gene essential to triggering necroptotic cell death – a natural process that protects our body from infection. In some people this process can go awry and ...
New research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), suggests that exposure to low doses of radiation may contribute to an increased risk of diabetes.
The study by Dr Huan Hu and Dr Toshiteru Ohkubo from the Japanese National Institute of Occupational Safety and Health involved more than 6,000 out of around 20,000 emergency workers who responded to the radiation accident at the Fukushima Daiichi Nuclear Power Plant, which was hit by a huge tsunami in March 2011.
Substantial amounts of radioactive materials were released into the environment following explosions at the ...
Real-world data from an ongoing international audit of testosterone deficiency in men with type 2 diabetes, being presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), suggests that testosterone replacement therapy (TRT) improves glycaemic control for up to 2 years.
The early data from 37 centres across 8 countries who have so far joined the Association of British Clinical Diabetologists (ABCD) audit , suggest that the reason that HbA1c (a measure of average blood sugar levels over the past 2-3 months) continues ...
New research presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), shows that treatment with the drug semaglutide significantly improves blood sugar control and weight loss in adults with type 2 diabetes for up to three years.
“Our long-term analysis of semaglutide in a large and diverse cohort of patients with type 2 diabetes found a clinically relevant improvement in blood sugar control and weight loss after 6 months of treatment, comparable with that seen in randomised trials”, says Professor Avraham Karasik from the Institute of Research and Innovation at Maccabi Health Services ...
Drinking dark tea every day may help to mitigate type 2 diabetes risk and progression in adults through better blood sugar control, suggests new research at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct).
The study, by researchers from the University of Adelaide in Australia and Southeast University in China, found that compared with never tea drinkers, daily consumers of dark tea had 53% lower risk for prediabetes and 47% reduced risk for type 2 diabetes, even after taking into account established risk factors known to drive the risk for diabetes, including age, ...
Soon after he joined UC Riverside in 2015, Maurizio Pellecchia, a professor of biomedical sciences in the UCR School of Medicine, began working with the UCR Research and Economic Development office to create on campus an incubator space. He envisioned that space as a home for UCR scientists to create startup companies to prove the commercial potential of their technologies. That multi-year effort helped create in the Multidisciplinary Research Building the EPIC Life Sciences Incubator that currently houses young companies in agricultural technology, biomedical technologies, bioengineering, and medicinal chemistry.
One of the tenant companies in the incubator ...
Commercial whaling in the 20th century decimated populations of large whales but also appears to have had a lasting impact on the genetic diversity of today’s surviving whales, new research from Oregon State University shows.
Researchers compared DNA from a collection of whale bones found on beaches near abandoned whaling stations on South Georgia Island in the south Atlantic Ocean to DNA from whales in the present-day population and found strong evidence of loss of maternal DNA lineages among blue and humpback whales.
“A maternal lineage is often associated with an animal’s cultural memories such as feeding and breeding locations that are passed from one generation ...
Viruses in soil may not be as destructive to bacteria as once thought and could instead act like lawnmowers, culling older cells and giving space for new growth, according to research out of the University of California, Davis, published Sept. 28 in the journal Nature Ecology and Evolution.
How viruses affect ecosystems, including bacteria, is challenging to untangle because they are complex and change over time and space. But the first annual rain on Mediterranean ecosystems, such as those in California, offers a kind of reset, triggering activity that can be observed.
The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando, Florida, putting the spotlight on the value of ACC Accreditation and NCDR services to enhance health care quality. Cardiovascular clinicians and stakeholders across the U.S. will converge at this year’s Summit to discuss the role of accreditation and registries in health equity initiatives, best practices for rebooting and rebranding health care quality, and strategies to engage the CV team in the quality process.
Embargoed for release until 5:00 p.m. ET on Monday 2 October 2023
Annals of Internal Medicine Tip Sheet
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
LAST 30 PRESS RELEASES:
[Press-News.org] USC joins LA-area stem cell institutes in forming a regenerative medicine consortium